Biopolymers codelivering engineered T cells and STING agonists can eliminate heterogeneous tumors. [electronic resource]
Producer: 20170926Description: 2176-2191 p. digitalISSN:- 1558-8238
- Adoptive Transfer
- Animals
- Antigen-Presenting Cells -- physiology
- Antineoplastic Agents -- administration & dosage
- Biopolymers -- administration & dosage
- Carcinoma, Pancreatic Ductal -- immunology
- Cell Line, Tumor
- Cyclic GMP -- administration & dosage
- Drug Carriers -- administration & dosage
- Female
- Implants, Experimental
- Melanoma, Experimental -- immunology
- Membrane Proteins -- agonists
- Mice, Inbred C57BL
- Mice, Transgenic
- Neoplasm Transplantation
- Pancreatic Neoplasms -- immunology
- T-Lymphocytes -- physiology
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.